Epileptogenic drugs: a systematic review

References

• Porter J, Jick M. Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms.Lancet1(8011), 587–588 (1977).
   PubMed Web of Science ®Google Scholar
• Messing RO, Clausson RG, Simon RP. Drug-induced seizures: a 10-year experience.Neurology34(12), 1582–1586 (1984).
   PubMed Web of Science ®Google Scholar
• De Lorenzo RJ, Hauser WA, Towne AR et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia.Neurology46(4), 1029–1035 (1996).
   PubMed Web of Science ®Google Scholar
• Garcia PA, Allredge BK. Drug-induced seizures.Neurol. Clin.12(1), 85–99 (1994).
   PubMedGoogle Scholar
• Schlesselman JJ (Ed.).Case–control studies. Design, Conduct, Analysis. Oxford University Press, NY, USA (1977).
   Google Scholar
• Ottman R. An epidemiologic approach to gene–environment interaction.Genet. Epidemiol.7(3), 177–185 (1990).
   PubMed Web of Science ®Google Scholar
• Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review.Am. J. Ther.9(1), 180–185 (2000).
   Google Scholar
• Nadvi S, Sarnaik S, Ravindranath Y. Low frequency of meperidine-associated seizures in sickle cell disease.Clin. Pediatr.38(8), 459–462 (1999).
   PubMedGoogle Scholar
• Kaiko RF, Foley KM, Grabinski PY et al. Central nervous system excitatory effects of meperidine in cancer patients.Ann. Neurol.13(2), 180–185 (1983).
   PubMed Web of Science ®Google Scholar
• Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (part II).Anesth. Analg.70(4), 433–44 (1990).
   PubMed Web of Science ®Google Scholar
• Walder B, Tramèr MR, Seeck M. Seizure-like phenomena and propofol: a systematic review.Neurology58(9), 1327–1332 (2002).
   PubMed Web of Science ®Google Scholar
• Yli-Hankala A, Vakkuri A, Sarkela M, Lindgren L, Korttila K, Jantti V. Epileptiform electroencephalogram during mask induction of anesthesia with sevoflurane.Anesthesiology91(6), 1596–1603 (1999).
   PubMedGoogle Scholar
• Vakkuri A, Jantti V, Sarkela M, Lindgren L, Korttila K, Yli-Hankala A. Epileptiform EEG during sevoflurane mask induction: effect of delaying the onset of hyperventilation.Acta Anaesthesiol. Scand.44(6), 713–719 (2000).
   PubMedGoogle Scholar
• Vakkuri A, Yli-Hankala A, Sarkela M et al. Sevoflurane mask induction of anaesthesia is associated with epileptiform EEG in children.Acta Anaesthesiol. Scand.45(7), 805–811 (2001).
   PubMed Web of Science ®Google Scholar
• Nieminen K, Western-Punnonen S, Kokki H, Ypparila H, Hyvarinen A, Partanen J. Sevoflurane anaesthesia in children after induction of anaesthesia with midazolam and thiopental does not cause epileptoform EEG.Br. J. Anaesth.89(6), 853–856 (2002).
   PubMedGoogle Scholar
• Jaaskelainen SK, Kaisti K, Suni L, Hinkka S, Scheinin H. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anaesthesia.Neurology61, 1073–1078 (2003).
   PubMedGoogle Scholar
• Lietman PS. Fluoroquinolone toxicities. An update.Drugs49(Suppl. 2), 159–163 (1995).
   PubMedGoogle Scholar
• O’Donnel JA, Gelone SP, Fluorquinolones.Infect. Dis. Clin. North Am.14(2), 489–513 (2000).
   PubMedGoogle Scholar
• Tack KJ, Smith JA. The safety profile of ofloxacin.Am. J. Med.87(Suppl. 6c), 78–81(1989).
   Google Scholar
• Fink MP, Snydman DR, Niederman MS et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized double-blind trial comparing intravenous ciprofloxacin with imipenem/cilastatin.Antimicrob. Agents Chemother.38(3), 547–557 (1994).
   PubMed Web of Science ®Google Scholar
• Christie MJ, Wong K, Ting RH, Tam PY, Sikaneta TG. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.Ann. Pharmacother.39(5), 953–955 (2005).
   PubMedGoogle Scholar
• Wong VK, Wright GT Jr, Ross LA et al. Imipenem/cilastatin treatment of bacterial meningitis in children.Pediatr. Infect. Dis. J.10(2), 122–125 (1991).
   PubMed Web of Science ®Google Scholar
• Koppel BS, Hauser WA, Politis C, van Duin D, Daras M. Seizures in the critically ill: the role of imipenem.Epilepsia42(12), 1590–1593 (2001).
   PubMed Web of Science ®Google Scholar
• Eng RHK, Munsif AN, Yangco BG, Smith SM, Chmel H. Seizure propensity with imipenem.Arch. Int. Med.149(8), 1881–1883 (1989).
   PubMedGoogle Scholar
• Calandra G, Lydick E, Cardigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.Am. J. Med.84(5), 911–918 (1988).
   PubMed Web of Science ®Google Scholar
• Schmutzard E, Williams KJ, Vukmirovits G et al. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults.J. Antimicrob. Chemother.36(Suppl. A), 85–97 (1995).
   PubMedGoogle Scholar
• Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP. Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system.Ann. Pharmacother.27(4), 497–501 (1993).
   PubMed Web of Science ®Google Scholar
• Brismar B, Malmborg AS, Tunevall G et al. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.J. Antimicrob. Chemother.35(1), 139–148 (1995).
   PubMed Web of Science ®Google Scholar
• Odio CM, Puig GR, Feris JM et al. Prospective, randomised, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children.Pediatr. Infect. Dis. J.18(7), 581–590 (1999).
   PubMed Web of Science ®Google Scholar
• Wallace KL. Antibiotic-induced convulsions.Crit. Care Clin.13(4), 741–762 (1997).
   PubMed Web of Science ®Google Scholar
• Bradley JS, Garau J, Lode H, Rolston KV, Wilson SE, Quinn JP. Carbapenems in clinical practice: a guide to their use in serious infection. Int. J. Antimicrob. Agents11(2), 93–100 (1999).
   PubMed Web of Science ®Google Scholar
• Kamei C, Sunami A, Tasaka K. Epileptogenic activity of cephalosporins in rats and their structure–activity relationship.Epilepsia24(4), 431–439 (1983).
   PubMedGoogle Scholar
• Schliamser SE, Cars O, Norrby SR. Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis.J. Antimicrob. Chemother.27(4), 405–425 (1991).
   PubMed Web of Science ®Google Scholar
• Neu HC. Safety of cefepime: a new extended-spectrum parenteral cephalosporin.Am. J. Med.100(6A), 68S–75S (1996).
   PubMedGoogle Scholar
• Dunner DL, Zisook S, Billow AA et al. A prospective surveillance study for bupropion sustained-release in the treatment of depression.J. Clin. Psychiatry59(7), 366–373 (1998).
   PubMed Web of Science ®Google Scholar
• Davidson J. Seizures and bupropion: a review.J. Clin. Psychiatry50(7), 256–261 (1989).
   PubMed Web of Science ®Google Scholar
• Settle EC, Stahl SM, Batey SR et al. Safety profile of sustained-release bupropion in depression: results of three clinical trials.Clin. Ther.21(3), 454–463 (1999).
   PubMed Web of Science ®Google Scholar
• Johnston JA, Lienberry CG, Ascher JA et al. A 102-center prospective study of seizure in association with bupropion.J. Clin. Psychiatry52(11), 450–456 (1991).
   PubMed Web of Science ®Google Scholar
• Skowron DM, Stimmel GL. Antidepressants and the risk of seizures.Pharmacotherapy12(1), 18–22 (1992).
   PubMedGoogle Scholar
• Dessain EC, Schatzberg AF, Woods BT, Cole JO. Maprotiline treatment in depression: a perspective on seizures.Arch. Gen. Psychiatry43(1), 86–90 (1986).
   PubMedGoogle Scholar
• Jabbari B, Bryan GE, Marsh EE, Gunderson CH. Incidence of seizures with tricyclic and tetracyclic antidepressants.Arch. Neurol.42(5), 480–481 (1985).
   PubMed Web of Science ®Google Scholar
• Baumann PA, Maitre L. Neurobiochemical aspects of maprotiline (Ludiomil) action.J. Int. Med. Res.7(5), 391–400 (1979).
   PubMedGoogle Scholar
• Swinkels JA, de Jonghe F. Safety of antidepressants.Int. Clin. Psychopharmacol.9(4), 19–25 (1995).
   PubMedGoogle Scholar
• Lowry MB, Dunne FJ. Seizures during tricyclic therapy.Am. J. Psychiatry137(11), 1461–1462 (1980).
   PubMedGoogle Scholar
• Noyes R Jr, Garvey MJ, Cook BL, Samuelson L. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.J. Clin. Psychiatry50(5), 163–169 (1989).
   PubMed Web of Science ®Google Scholar
• Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.Epilepsia40(Suppl. 10), 48–56 (1999).
   PubMedGoogle Scholar
• Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience.Biochem. Pharmacol.52, 1323–1329 (1996).
   PubMed Web of Science ®Google Scholar
• Ebert U. Basic mechanisms of psychotropic drugs.Epilepsia43(Suppl. 2), 2–7 (2002).
   PubMedGoogle Scholar
• Ascher JA, Cole JO, Colin JN et al. Bupropion: a review of its mechanism of antidepressant activity.J. Clin. Psychiatry56, 395–401 (1995).
   PubMed Web of Science ®Google Scholar
• Williams SA, Makker SP, Grupe WE. Seizures: a significant side effect of chlorambucil therapy in children.J. Pediatr.93(3), 516–518 (1978).
   PubMed Web of Science ®Google Scholar
• Jourdan E, Topart D. Chlorambucil/prednisone-induced seizures in a patient with non-Hodgkin’s lymphoma.Am. J. Hematol.67(2), 147–149 (2001).
   PubMedGoogle Scholar
• Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures.Neurology41(3), 369–371 (1991).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Meltzer HY. Clozapine-induced myoclonus and generalized seizures.Biol. Psychiatry39(5), 367–370 (1996).
   PubMedGoogle Scholar
• Pacia SV, Devinsky O. Clozapine-related seizures: experience with 5629 patients.Neurology44(12), 2247–2249 (1994).
   PubMed Web of Science ®Google Scholar
• Kumra S, Frazier JA, Jacobsen LK, McKenna K. Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison.Arch. Gen. Psychiatry53(12), 1090–1097 (1996).
   PubMed Web of Science ®Google Scholar
• Freudenreich O, Weiner RD, McEvoy JP. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.Biol. Psychiatry42(2), 132–137 (1997).
   PubMedGoogle Scholar
• Silvestri RC, Bromfield EB, Khoshbin S. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients.Ann. Pharmacother.32(11), 1147–1151 (1998).
   PubMed Web of Science ®Google Scholar
• Logothetis J. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy.Neurology17(9), 869–877 (1967).
   PubMed Web of Science ®Google Scholar
• Soucachet P, Dousinet P, D’Alteroche B. Manifestations cliniques comitiales au cours du traitement par la chlorpromazine.Rev. Neurol.95(6), 566 (1956).
   PubMedGoogle Scholar
• Szatmari A. Clinical and electroencephalogram investigation on largactil in psychosis (preliminary study).Am. J. Psychiatry112(10), 788–794 (1956).
   PubMedGoogle Scholar
• Lomas J, Boardman RH, Markowe M. Complications of chlorpromazine therapy in 800 mental-hospital patients.Lancet268(6875), 1144–1147 (1955).
   PubMedGoogle Scholar
• Schlichter W, Bristow ME, Schultz S, Henderson AL. Seizures occuring during intensive chlorpromazine therapy.Can. Med. Assoc. J.74(5), 364–366 (1956).
   PubMedGoogle Scholar
• Feldman PE. Clinical evaluation of chlorpromazine therapy for mental illness: analysis of one year’s experience.J. Clin. Exp. Psychopath.18, 1 (1957).
   PubMedGoogle Scholar
• Bird EG, Goss JD Jr., Denber HCB. Chlorpromazine in the treatment of mental illness: a study of 750 patients.Am. J. Psychiatry111(12), 930 (1955).
   PubMedGoogle Scholar
• Kuztke JF. Seizures with promazine. Preliminary report.J. Nerv. Ment. Dis.125(1), 119–125 (1957).
   PubMedGoogle Scholar
• Trimble M. The relationship between epilepsy and schizophrenia: a biochemical hypothesis.Biol. Psychiatry12(2), 299–304 (1977).
   PubMedGoogle Scholar
• Itil TM, Soldatos C. Epileptogenic side effects of psychotropic drugs. Practical recommendations.JAMA244(13), 1460–1463 (1980).
   PubMed Web of Science ®Google Scholar
• Witten DM, Hirsch FD, Hartman GW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states.Am. J. Roentgenol. Radium Ther. Nucl. Med.119(4), 832–840 (1973).
   PubMedGoogle Scholar
• Nelson M, Bartlett RJV, Lamb JT. Seizures after intravenous contrast media for cranial computed tomography.J. Neurol. Neurosurg. Psychiatry52(10), 1170–1175 (1989).
   PubMedGoogle Scholar
• LoZito JC. Convulsions: a complication of contrast enhancement in computerized tomography.Arch. Neurol.34(10), 649–650 (1977).
   PubMedGoogle Scholar
• Scott WR. Seizures: a reaction to contrast media for computed tomography of the brain.Radiology137(2), 359–361 (1980).
   PubMedGoogle Scholar
• Choi EJ, Kang JK, Lee SA, Kim KH, Lee SG, Andermann F. New-onset seizures after liver transplantation: clinical implications and prognosis in survivors.Eur. Neurol.52(4), 230–236 (2004).
   PubMedGoogle Scholar
• Wijkicks EFM, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients.Neurology47(6), 1523–1525 (1996).
   PubMedGoogle Scholar
• Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients – incidence, timing, and long-term follow-up.Clin. Transplant.14(1), 1–7 (2000).
   PubMedGoogle Scholar
• Erer B, Polchi P, Lucarelli G, Angelucci E et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.Bone Marrow Transplant.18(1), 157–162 (1996).
   PubMed Web of Science ®Google Scholar
• Ghany AM, Tutschka PJ, McGhee RB et al. Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy.Transplantation52(2), 310–315 (1991).
   PubMedGoogle Scholar
• Trullemans F, Grignard F, Van Camp B, Schots R. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogenic bone marrow transplantation.Eur. J. Haematol.67(2), 94–99 (2001).
   PubMedGoogle Scholar
• Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon.J. Hepatol.24(1), 38–47 (1996).
   PubMed Web of Science ®Google Scholar
• Calvet MC, Gresser I. Interferon enhances the excitability of cultured neurons.Nature278(5704), 558–560 (1979).
   PubMedGoogle Scholar
• Kunisaki TA, Augenstein WL. Drug- and toxin-induced seizures.Emerg. Med. Clin. North Am.12(4), 1027–1053 (1994).
   PubMedGoogle Scholar
• Bahls FH, Kelvin K, Bird TD. Theophylline-associated seizures with “therapeutic” or low toxic serum concentrations: risk factors for serious outcome in adults.Neurology41(1), 1309–1312 (1991).
   PubMedGoogle Scholar
• Chin JH. Adenosine receptors in brain: neuromodulation and role in epilepsy.Ann. Neurol.26(6), 276–279 (1989).
   Google Scholar
• Weinstein RS. Recognition and management of poisoning with B-adrenergic blocking agents.Ann. Emerg. Med.13(12), 1123–1135 (1984).
   PubMed Web of Science ®Google Scholar
• Zaccara G, Muscas GC, Messori A. Clinical features, pathogenesis and management of drug-induced seizures.Drug Saf.5(2), 109–151 (1990).
   PubMed Web of Science ®Google Scholar
• Gasse C, Derby L, Vasiliskas-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol.Pharmacotherapy20(6), 629–634 (2000).
   PubMed Web of Science ®Google Scholar
• Franson HL, Hay DP, Neppe V et al. Drug-induced seizures in the elderly. Causative agents and optimal management.Drugs Aging7(1), 38–48 (1995).
   PubMedGoogle Scholar
• Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures.Epilepsia39(1), 5–17 (1998).
   PubMed Web of Science ®Google Scholar
• Leber P. “Time-less” risks (a hazard of risk assessment: the example of seizure and antidepressants).Psychopharmacology Bull.21(2), 334–338 (1985).
   PubMedGoogle Scholar
• Hauser WA. Incidence and prevalence. In:Epilepsy: A Comprehensive Textbook. Engel J Jr, Pedley TA (Eds). Lippincot-Raven, PA, USA, 47–57 (1997).
   Google Scholar
• Delanty N, Vaughan CJ, French JA. Medical causes of seizures.Lancet352(9125), 383–390 (1998).
   PubMed Web of Science ®Google Scholar
• Annegers JF, Hauser WA, Lee JRJ, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935–1984.Epilepsia36(4), 327–333 (1995).
   Google Scholar